Search

everythinglearnresearchcommunity

for

Search:↓

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

A man with scalp and neck skin issues improved after a year of oral isotretinoin.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

A man with skin and hair symptoms improved partially with specific treatment.

Dermoscopy helped diagnose discoid lupus erythematosus in two patients without needing skin biopsies.

A rare skin condition affected only the facial hair of a 46-year-old man.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

A young man was diagnosed with a rare hair loss condition usually seen in older women.

Two unusual cases showed that Lichen Planopilaris can look like other skin conditions and need early treatment to protect hair.

Nilotinib can cause skin issues like red bumps and hair loss.

Topical treatments like AHAs, BHAs, and urea may help keratosis pilaris, but evidence is limited.

Transplant patients often get skin problems, with treatments varying by condition.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Early treatment of acne is crucial to prevent scarring and psychological effects.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

The chapter explains that there are many genetic skin disorders affecting skin cell formation, including both common and rare types.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

The article concludes that schoolchildren and adolescents experienced various skin issues during the COVID-19 pandemic, including acne from masks and other skin reactions from the virus and vaccines.

Nilotinib can cause generalized keratosis pilaris.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.